In episode 563, Mike and James go over all the RCT evidence for the Respiratory Syncytial Virus (RSV) vaccine in older adults. You need to know the vaccine works, but you really need to know the baseline risk of RSV before anyone can really make an informed decision about this vaccine. We’ll do our best to give you all the numbers.

Show notes
Preventing RSV in the elderly

MAKING EVIDENCE MATTER for EVERYONE CONFERENCE
Vancouver
May 24/25, 2024

In episode 562, Mike and James continue to discuss our recently revised 2023 simplified lipid guidelines with Adrienne and Mike. We talk about all the medications used for cardiovascular risk reduction. We go over all the evidence and all the numbers for the benefits (and sometimes lack of benefit) and the harms. We also specifically talk about how to deal with statin intolerance.

Show notes

1) PEER simplified lipid guideline 2023 update
2) Lipid-lowering therapies for cardiovascular disease prevention and management in primary care – PEER umbrella systematic review of systematic reviews
3) Simplified Cardiovascular Decision Aid

In episode 561, Mike and James invite Adrienne Lindblad and Mike Kolber to discuss our recently revised 2023 simplified lipid guidelines. We talk about the guideline process, the best available evidence, and discuss some of the rationale we used to recommend the simpler approaches outlined in our guideline. As always, the focus was on shared decision-making and the time needed to treat. Have a listen and see what you think.

Show notes

1) PEER simplified lipid guideline 2023 update
2) Lipid-lowering therapies for cardiovascular disease prevention and management in primary care – PEER umbrella systematic review of systematic reviews
3) Simplified Cardiovascular Decision Aid